These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32902359)

  • 21. Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis.
    Mercier T; Guldentops E; Lagrou K; Maertens J
    Clin Infect Dis; 2021 May; 72(9):1577-1584. PubMed ID: 32188971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
    Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Fungal Infections. A Systematic Review and Meta-Analysis Supporting American Thoracic Society Practice Guideline.
    Haydour Q; Hage CA; Carmona EM; Epelbaum O; Evans SE; Gabe LM; Knox KS; Kolls JK; Wengenack NL; Prokop LJ; Limper AH; Murad MH
    Ann Am Thorac Soc; 2019 Sep; 16(9):1179-1188. PubMed ID: 31219341
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a nano-gold immunodiagnostic assay for rapid on-site detection of invasive aspergillosis.
    Raval KM; Ghormade V; Rajamohanan PR; Choudhary H; Rudramurthy SM; Chakrabarti A; Paknikar K
    J Med Microbiol; 2019 Sep; 68(9):1341-1352. PubMed ID: 31355743
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis and treatment of invasive aspergillosis as a main determinant of outcome - review of literature according to the presented case report.
    Borys M; Piwowarczyk P; Sysiak J; Czuczwar M; Prystupa A
    Ann Agric Environ Med; 2017 Mar; 24(1):100-103. PubMed ID: 28378982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the lateral flow Aspergillus assay for the diagnosis of invasive aspergillosis, experience in a university hospital].
    Delama I; Legarraga P; González T; García P; Rabagliati R
    Rev Chilena Infectol; 2018; 35(5):574-579. PubMed ID: 30725006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
    Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
    Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis in European Hospitals: A Survey from Belgium and a Literature Review of Test Performances in Different Patient Populations.
    Aerts R; Cuypers L; Mercier T; Maertens J; Lagrou K
    Mycopathologia; 2023 Oct; 188(5):655-665. PubMed ID: 37209228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
    Danylo A; Courtemanche C; Pelletier R; Boudreault AA
    Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspergillus galactomannan detection: Trichoderma as a cause of positive results.
    Markantonatou AM; Samaras K; Yannaki E; Zachrou E; Vyzantiadis TA
    Curr Microbiol; 2019 Jan; 76(1):48-51. PubMed ID: 30310968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.
    Hoenigl M; Orasch T; Faserl K; Prattes J; Loeffler J; Springer J; Gsaller F; Reischies F; Duettmann W; Raggam RB; Lindner H; Haas H
    J Infect; 2019 Feb; 78(2):150-157. PubMed ID: 30267801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local retrospective analysis of galactomannan cut-off values in bronchoalveolar lavage fluids for diagnosis of invasive aspergillosis.
    Bellanger AP; Gbaguidi-Haore H; Tatoyan N; Berceanu A; Scherer E; Millon L
    Folia Microbiol (Praha); 2018 Nov; 63(6):757-761. PubMed ID: 29846912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
    Xie LP; Liu T; Meng WT; Zhou J
    Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current approaches to diagnose invasive aspergillosis: application of real-time automated polymerase chain reaction].
    Kami M
    Nihon Ishinkin Gakkai Zasshi; 2001; 42(4):181-8. PubMed ID: 11704742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.